N-[3-Methoxy-4-(2-methyl-acridin-9-ylamino)-phenyl]-methanesulfonamide

ID: ALA9821

Chembl Id: CHEMBL9821

Cas Number: 79453-36-4

PubChem CID: 154953

Max Phase: Preclinical

Molecular Formula: C22H21N3O3S

Molecular Weight: 407.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccc(C)cc12

Standard InChI:  InChI=1S/C22H21N3O3S/c1-14-8-10-19-17(12-14)22(16-6-4-5-7-18(16)23-19)24-20-11-9-15(13-21(20)28-2)25-29(3,26)27/h4-13,25H,1-3H3,(H,23,24)

Standard InChI Key:  BLINWSYJRUDTKJ-UHFFFAOYSA-N

Associated Targets(non-human)

Calf thymus DNA (4845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus sp. (1192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.50Molecular Weight (Monoisotopic): 407.1304AlogP: 4.82#Rotatable Bonds: 5
Polar Surface Area: 80.32Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.83CX Basic pKa: 8.51CX LogP: 3.68CX LogD: 2.63
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -1.26

References

1. Rewcastle GW, Atwell GJ, Baguley BC, Denny WA..  (1984)  Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.,  27  (8): [PMID:6747989] [10.1021/jm00374a020]
2. Atwell GJ, Baguley BC, Finlay GJ, Rewcastle GW, Denny WA..  (1986)  Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.,  29  (9): [PMID:3755758] [10.1021/jm00159a035]
3. Denny WA, Cain BF, Atwell GJ, Hansch C, Panthananickal A, Leo A..  (1982)  Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.,  25  (3): [PMID:7069706] [10.1021/jm00345a015]
4. Baguley BC, Denny WA, Atwell GJ, Cain BF..  (1981)  Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.,  24  (5): [PMID:6894620] [10.1021/jm00137a009]

Source